- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
- Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
- Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
- Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
- Arcus Biosciences to Participate in Two Upcoming Investor Conferences
More ▼
Key statistics
On Wednesday, Arcus Biosciences Inc (RCUS:NYQ) closed at 16.75, 29.34% above the 52 week low of 12.95 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.13 |
---|---|
High | 17.56 |
Low | 16.73 |
Bid | 16.45 |
Offer | 18.40 |
Previous close | 17.24 |
Average volume | 686.86k |
---|---|
Shares outstanding | 90.95m |
Free float | 53.82m |
P/E (TTM) | -- |
Market cap | 1.57bn USD |
EPS (TTM) | -3.10 USD |
Data delayed at least 15 minutes, as of May 23 2024 00:00 BST.
More ▼